|
Post by babaoriley on Jun 3, 2018 11:35:54 GMT -5
Yes. In the public affairs field, so my photo/name is out there. I do re-tweet MNKD and post work stuff. I hope you continue to post here, shiv. You're obviously a very good writer, I can tell that from the few posts you've made. Short, direct sentences. I tend to ramble, with lots of commas and clauses.
As to your entry point in MNKD, well, if I'd never been in it at the time of approval, I think I would have jumped in. I'm sure many felt it was too risky before approval, and decided it was best to wait for the approval that would make it a SURE winner. Ironic.
|
|
|
Post by mannmade on Jun 3, 2018 11:55:23 GMT -5
Baba you are a lawyer. You have to use a minimum amoount of commas in every sentence just to pass the bar exam. We are taught in law school if you cant dazzel them with brillance baffle them with BS...
|
|
|
Post by sayhey24 on Jun 3, 2018 14:22:55 GMT -5
DBC - Lets see what happens. Once GWPH gets their product approved RLS just needs to show non-inferiority with an already approved inhalation device. The RLS trials could go pretty quick.
|
|
|
Post by dreamboatcruise on Jun 3, 2018 14:58:59 GMT -5
DBC - Lets see what happens. Once GWPH gets their product approved RLS just needs to show non-inferiority with an already approved inhalation device. The RLS trials could go pretty quick. Well, dronabinol is already approved which is the API being targeted first (per MNKD presentation). Might that lead to some faster approval with less trials? Treprostinil seems to be the same situation. It is shortened process but still 3 years from the start of the first clinical trial. I guess unless there is some argument that technosphere dronabinol would be different, I'd use TrepT as a reference for expectation.
|
|
|
Post by mannmade on Jun 3, 2018 18:09:54 GMT -5
Something else I have noticed recently... It has to do with what I like to call the "collective voice." In the beginning post FDA approval, most of the anecdotal information about Afrezza and how well it worked, was posted by the early adopters, Sam, Eric, Laura Afrezza Guy, Matty B, and a couple of others whom after a while, with all respect, I started to view as the "Usual Suspects."
Next Mike Hoskins from d mine who was originally skeptical about Afrezza came around to where he takes his extended pump breaks and relies on Afrezza for his TIR.
Then sometime about a year ago or so we saw the next generation of Afrezza users such as Kevin M, Lilly, John, Brendan Laureen, etc... starting to take to social media, as ironically the Usual Suspects were now posting much less although by all accounts still very positive and active with Afrezza.
And now I am hearing from a ariety of what I consider very credible sources, new anedoctal stories about how PCP's and Endos are starting to ask about Afrezza. One CGM rep has said that they are starting to see more endos and docs ask about Afrezza. I just saw a FB post on ST about a person whose endo actually volunteered info on Afrezza and recommend they try it. When they went to get the script their insurance approved it right away. Then there is the parent here on PB's looking for help to prescribe to their child who is under 18.
Now admittely this is all anecdotal information but there is a nice progression taking place... in the conversation of the "Collective Voice..."
To me it is the Perfect Storm that is brewing when you take all of this in context of CGM penetration growing, conversations about importance of TIR vs Hba1c, ADA review of SOC, and everything else we have discussed here on PB. And remember... nothing else on the market comes close to managing TIR at mealtime...
I suspect it will take another 12 to 24 months to start to see enough weekly scripts that begin to challenge Humalog and Novolog but it feels like Mannkind is on the way.
The shorts better get ready to put on their "Big Boy Pants" as their party is almost over and the house lights are starting to blink on and off imho... "The answers my friend(s) are blowin in the wind..."
|
|
|
Post by sayhey24 on Jun 3, 2018 18:28:37 GMT -5
Mannmade - if you are noticing this so are the CEOs of every diabetes BP. Right now I think its living rent fres in all their heads. Do you think MNKD will be around in two years? I will be surprised. The question is which one blinks first.
|
|
|
Post by golfeveryday on Jun 3, 2018 18:58:27 GMT -5
Something else I have noticed recently... It has to do with what I like to call the "collective voice." In the beginning post FDA approval, most of the anecdotal information about Afrezza and how well it worked, was posted by the early adopters, Sam, Eric, Laura Afrezza Guy, Matty B, and a couple of others whom after a while, with all respect, I started to view as the "Usual Suspects." Next Mike Hoskins from d mine who was originally skeptical about Afrezza came around to where he takes his extended pump breaks and relies on Afrezza for his TIR. Then sometime about a year ago or so we saw the next generation of Afrezza users such as Kevin M, Lilly, John, Brendan Laureen, etc... starting to take to social media, as ironically the Usual Suspects were now posting much less although by all accounts still very positive and active with Afrezza. And now I am hearing from a ariety of what I consider very credible sources, new anedoctal stories about how PCP's and Endos are starting to ask about Afrezza. One CGM rep has said that they are starting to see more endos and docs ask about Afrezza. I just saw a FB post on ST about a person whose endo actually volunteered info on Afrezza and recommend they try it. When they went to get the script their insurance approved it right away. Then there is the parent here on PB's looking for help to prescribe to their child who is under 18. Now admittely this is all anecdotal information but there is a nice progression taking place... in the conversation of the "Collective Voice..." To me it is the Perfect Storm that is brewing when you take all of this in context of CGM penetration growing, conversations about importance of TIR vs Hba1c, ADA review of SOC, and everything else we have discussed here on PB. And remember... nothing else on the market comes close to managing TIR at mealtime... I suspect it will take another 12 to 24 months to start to see enough weekly scripts that begin to challenge Humalog and Novolog but it feels like Mannkind is on the way. The shorts better get ready to put on their "Big Boy Pants" as their party is almost over and the house lights are starting to blink on and off imho... "The answers my friend(s) are blowin in the wind..." my son, recently 18 and diagnosed with Type 1 8 weeks ago, has a follow up appointment on Tuesday and the nurse mentioned Afrezza without even asking about it. 8 weeks ago the Ped Endo said Afrezza ‘really was just for T2’s’. 😳 I believe we will be walking away with a Rx on Tuesday. Yes, seems like things are moving in the right direction.
|
|
|
Post by olebob1 on Jun 3, 2018 19:16:34 GMT -5
Something else I have noticed recently... It has to do with what I like to call the "collective voice." In the beginning post FDA approval, most of the anecdotal information about Afrezza and how well it worked, was posted by the early adopters, Sam, Eric, Laura Afrezza Guy, Matty B, and a couple of others whom after a while, with all respect, I started to view as the "Usual Suspects." Next Mike Hoskins from d mine who was originally skeptical about Afrezza came around to where he takes his extended pump breaks and relies on Afrezza for his TIR. Then sometime about a year ago or so we saw the next generation of Afrezza users such as Kevin M, Lilly, John, Brendan Laureen, etc... starting to take to social media, as ironically the Usual Suspects were now posting much less although by all accounts still very positive and active with Afrezza. And now I am hearing from a ariety of what I consider very credible sources, new anedoctal stories about how PCP's and Endos are starting to ask about Afrezza. One CGM rep has said that they are starting to see more endos and docs ask about Afrezza. I just saw a FB post on ST about a person whose endo actually volunteered info on Afrezza and recommend they try it. When they went to get the script their insurance approved it right away. Then there is the parent here on PB's looking for help to prescribe to their child who is under 18. Now admittely this is all anecdotal information but there is a nice progression taking place... in the conversation of the "Collective Voice..." To me it is the Perfect Storm that is brewing when you take all of this in context of CGM penetration growing, conversations about importance of TIR vs Hba1c, ADA review of SOC, and everything else we have discussed here on PB. And remember... nothing else on the market comes close to managing TIR at mealtime... I suspect it will take another 12 to 24 months to start to see enough weekly scripts that begin to challenge Humalog and Novolog but it feels like Mannkind is on the way. The shorts better get ready to put on their "Big Boy Pants" as their party is almost over and the house lights are starting to blink on and off imho... "The answers my friend(s) are blowin in the wind..." mannmade, I am in complete agreement. The testimonials in the last 6 months have been amazing. We need to give a great big "Thank You" to Sports (especially), Harryx1, Joeypots, and many others that are so good at locating terrific testimonials and reposting to spread the wonderful news. I always have a large draft of hopium with my wine on Sunday nights, but Yes I am very optimistic. Unless we lose Sport, I think all is OK!
|
|
|
Post by sportsrancho on Jun 3, 2018 19:25:17 GMT -5
“The shorts better get ready to put on their "Big Boy Pants" as their party is almost over and the house lights are starting to blink on and off imho... "The answers my friend(s) are blowin in the wind..."
Love it love it! For the answers truly are blowing in the wind:-))
|
|
|
Post by sportsrancho on Jun 3, 2018 19:36:24 GMT -5
Patten......@rooksleanne I was told last week at a medical conference that Endo's in the Chicago/Indiana area's are also asking! Bullish
|
|
|
Post by mango on Jun 3, 2018 20:34:15 GMT -5
Yes. In the public affairs field, so my photo/name is out there. I do re-tweet MNKD and post work stuff. I hope you continue to post here, shiv. You're obviously a very good writer, I can tell that from the few posts you've made. Short, direct sentences. I tend to ramble, with lots of commas and clauses.
As to your entry point in MNKD, well, if I'd never been in it at the time of approval, I think I would have jumped in. I'm sure many felt it was too risky before approval, and decided it was best to wait for the approval that would make it a SURE winner. Ironic.
🧐
|
|
|
Post by sportsrancho on Jun 3, 2018 20:38:32 GMT -5
I hope you continue to post here, shiv. You're obviously a very good writer, I can tell that from the few posts you've made. Short, direct sentences. I tend to ramble, with lots of commas and clauses.
As to your entry point in MNKD, well, if I'd never been in it at the time of approval, I think I would have jumped in. I'm sure many felt it was too risky before approval, and decided it was best to wait for the approval that would make it a SURE winner. Ironic.
🧐 The reason I am close to break even is I bought eight months prior to the final FDA approval at two dollars a share. Took profits and bought back in lower later. Not low enough I might add.😎
|
|
|
Post by mango on Jun 3, 2018 20:43:06 GMT -5
Something else I have noticed recently... It has to do with what I like to call the "collective voice." In the beginning post FDA approval, most of the anecdotal information about Afrezza and how well it worked, was posted by the early adopters, Sam, Eric, Laura Afrezza Guy, Matty B, and a couple of others whom after a while, with all respect, I started to view as the " Usual Suspects." Next Mike Hoskins from d mine who was originally skeptical about Afrezza came around to where he takes his extended pump breaks and relies on Afrezza for his TIR. Then sometime about a year ago or so we saw the next generation of Afrezza users such as Kevin M, Lilly, John, Brendan Laureen, etc... starting to take to social media, as ironically the Usual Suspects were now posting much less although by all accounts still very positive and active with Afrezza. And now I am hearing from a ariety of what I consider very credible sources, new anedoctal stories about how PCP's and Endos are starting to ask about Afrezza. One CGM rep has said that they are starting to see more endos and docs ask about Afrezza. I just saw a FB post on ST about a person whose endo actually volunteered info on Afrezza and recommend they try it. When they went to get the script their insurance approved it right away. Then there is the parent here on PB's looking for help to prescribe to their child who is under 18. Now admittely this is all anecdotal information but there is a nice progression taking place... in the conversation of the "Collective Voice..." To me it is the Perfect Storm that is brewing when you take all of this in context of CGM penetration growing, conversations about importance of TIR vs Hba1c, ADA review of SOC, and everything else we have discussed here on PB. And remember... nothing else on the market comes close to managing TIR at mealtime... I suspect it will take another 12 to 24 months to start to see enough weekly scripts that begin to challenge Humalog and Novolog but it feels like Mannkind is on the way. The shorts better get ready to put on their "Big Boy Pants" as their party is almost over and the house lights are starting to blink on and off imho... "The answers my friend(s) are blowin in the wind..." The Usual Suspects by Afrezzauser circa 2015
|
|
|
Post by slugworth008 on Jun 3, 2018 20:48:01 GMT -5
The reason I am close to break even is I bought eight months prior to the final FDA approval at two dollars a share. Took profits and bought back in lower later. Not low enough I might add.😎 I would have continues averaging down over the past 8+ months to offset the effects of the 5/1 RS....but didn't have the funds to do so. Going forward that will start to change, however I see more dilution coming to keep the lights on so - as much as that will suck - At least it will keep the PPS down so I can add as inexpensively as possible. But with my luck that mythical "deal" will materialize before I can grab another a nice chunk of shares.
|
|
|
Post by mango on Jun 3, 2018 21:04:05 GMT -5
The reason I am close to break even is I bought eight months prior to the final FDA approval at two dollars a share. Took profits and bought back in lower later. Not low enough I might add.😎 Isn't that similar to what Mike did?
|
|